GISTs are typically driven by mutations of the receptor tyrosine kinase oncogene (C-KIT) or the platelet-derived growth factor receptor α (PDGFRα), which account for more than 80% and 5%–10% of all cases of GIST, respectively (3–5). Here, PDGFRA is linked to gastrointestinal stromal tumor.